Key result
PEDF activates microglia and NF-kappaB to induce chemokine production.
Many studies have shown that pigment epithelium-derived factor (PEDF) has neurotrophic effects on retinal cells and hippocampal, spinal cord, and cerebellar granule cell neurons, but much less work has examined the effects of PEDF on glia. In this study, we show that PEDF changes microglial morphology within 1 h of exposure, to a more deactivated form, while having no effect on the expression of such activation markers as OX-42 and ED-1. In contrast, urea activates acid phosphatase, and PEDF blocks that activation. PEDF also activates NFkappaB, accompanied by the induction of mRNAs and proteins for the chemokines macrophage inflammatory protein-1alpha (MIP-1alpha, MIP-2, and MIP-3alpha. All the chemokines stimulate acid phosphatase activity, and high doses of MIP-2 and MIP-3alpha), alter the morphology of the microglia at 1 h after treatment. These results suggest that the use of PEDF for clinical treatments, such as for retinal neovascularization, brain injury, or ischemia, should be undertaken with caution because of the possibility of induction of inflammation caused by microglial or other immune cell migration in response to the chemokines induced by PEDF.
No takes yet. Share an insight, caveat, or question.
Takanohashi et al. (2005) studied this question. Pigment epithelium-derived factor (PEDF) was evaluated on Microglial morphology and chemokine production. Pigment epithelium-derived factor (PEDF) changed rat microglial morphology and activated NFkappaB, inducing the production of chemokines such as MIP-1alpha, MIP-2, and MIP-3alpha.
Synapse has enriched 5 related papers. Consider them for comparative context: